Skip to main content
. 2024 Feb 13;50:100977. doi: 10.1016/j.neo.2024.100977

Fig. 5.

Fig 5

IHC analysis. (A) CD4+, CD8+, CD20+, FoxP3+, CD86+, CD56+, CD163+, CD11b+ at baseline and after neoadjuvant chemoimmunotherapy. (B) Radar map of IHC H scores. (C) Correlation between IC and CD8 H score.